Navigation Links
Glenmark Brings to the Notice of the Authorities Irregularities of the Clinical Investigator at its Jamnagar Site in Gujarat
Date:7/23/2009

MUMBAI, July 23 /PRNewswire-FirstCall/ --

- A Police Complaint has Been Lodged by Hospital Authorities Citing Fraudulent Activity by the Clinical Investigator Dr. A Bhattacharya Working at the GG Hospital and the MP Shah Medical College

- Glenmark Not Only Acts as the Whistle-Blower but Also Discontinues its Clinical Study at the Mentioned Site

After receiving approval from the Drug Controller General of India(DCGI) for a multi-centre Phase IIb clinical study for its lead COPD/asthma molecule, Oglemilast, Glenmark Pharmaceuticals Limited contracted Omnicare Clinical Research(Omnicare), a leading international CRO to conduct this Phase II asthma study on its behalf. Appropriate preclinical and clinical evaluations were completed prior to initiating this phase IIb asthma study. Being a multi-centre clinical study, one of the sites chosen was Guru Gobind Hospital, Jamnagar, Gujarat. Dr. A Bhattacharya, who was at that time working with the hospital was the clinical investigator for this mentioned site.

After Dr. Bhattacharya provided all necessary approvals and completed documentation, the site was initiated at the end of 2008. During monitoring activities immediately after initiation of the site, Omnicare suspected fraudulent activity. Without delay, Glenmark along with Omnicare carried out the appropriate for-cause audit and confirmed the fraud. This was immediately brought to the attention of the Chairman of the Ethics Committee at the concerned Hospital. Omnicare along with Glenmark acted swiftly and closed the site in line with normal regulatory requirements, to ensure the appropriate care/safety of the patients was protected. It is important to confirm that no patients have been put at risk, and no further patients have been or will be recruited in the clinical study at Jamnagar. Glenmark also immediately formally notified the DCGI of the situation at Dr Bhattacharya's site i
'/>"/>

SOURCE Glenmark Pharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. HealthPROSe Brings Creative, Strategic Thinking to Health Blogosphere
2. A Bundle of Joy Brings a Bundle of Questions - Life123.com Delivers the Answers!
3. As Fire Ants Continue to Proliferate, Hospital-Proven Burn Anesthetic Brings Instant Relief for Bites, Stings
4. Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together
5. USAID Brings White House Service Initiative to Baltimore
6. Opening Day of Fi Asia-China 2009 Brings the Food Ingredients Industry to Shanghai
7. Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village
8. White House Health Reform Stakeholder Discussion Brings Palliative Care to the Table
9. Best and Brightest Forum on Medical Innovation Brings Senator Arlen Specter, U.S. Representative Anna Eshoo, and Innovation Leaders Together in Washington, D.C., This Week
10. "Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America"
11. St. Louis Firm Brings Medicare Risk Adjustment to iPhone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., DELMAR,Calif.,Nov.25()/PRNewswire-FirstCall/-...ldings Corporation(PinkSheets:ADHC),announcedtoday...tionsplatform,enablinginvestorstoeasilyaccesstimel...ewsystemcanbeaccessedat: http://www.americandivers...isimportantandournewwebsiteallowsustoprovidereleva...
(Date:11/25/2009)...ditional South American medicinal herb proves effe.... 25 (HealthDay News) -- An herb called Brazilian ...drugs, English researchers report. , Traditiona...s crenata to treat a range of health problems, in...is study is the first to scientifically prove the ...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--IntroducingP...colorcosmeticsandadvancedskincarededicatedtoprovid...iBeautyisthefirstprestigeskincareandcolorcosmeticb...tistryStores,withofficesinSanFranciscoandToronto,w...ailprofessionalswithover35yearsexperienceintheindu...
(Date:11/25/2009)... Dr. Neil J. Zemmel, a board...hing a new website utilizing the latest internet t...t and breast reconstruction procedures. The new si...eate an interactive web experience that’s de...ual tour of Dr. Zemmel’s practice. , ...
(Date:11/25/2009)... The American Society of Hem...rsquo;s publishing, education, and media company, ...” a dynamic science curriculum designed to s...e, in addition to exposing students to exciting ca... Washington (PRWEB) November 25, 2009 --...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces New Website 2Health News:Pari Beauty Professional Artistry 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
...en just once per month, experts say , FRIDAY, Oct....g anemia in patients with severe kidney disease co...ing to a U.S. study. , Compared with conventional ...l Research Institute in New York, and colleagues. ...
...thopedic Institute of Chicago Offer Complimentary ...linical Study., CHICAGO, Oct. 19 , What: ... Stage IV breast cancer are eligib...ve for a protein called human epid...
...18 The following statement,is attributable to: Ro...Medical Association (AMA) welcomes today,s decisio...to issue a consumer warning,about the potentially ...med purchasers of health care. Achieving this goal...
...if., Oct. 18 The annual HMO,report card released ...ague,and incomplete that it does not allow consume...he report omits key consumer information including...CR)., FTCR noted that today,s release was timed t...
...18 The Association of,American Physicians and Sur...Serkes, director of policy and public affairs, in ...today to override President Bush,s veto,of a bill ...would,have spent almost as much money on doctors a...
...f., Oct. 18 Align,Technology, Inc. (Nasdaq: ALGN...od of straightening teeth without wires or bracket...ation Program by the Academy of General,Dentistry,... implementing continuing education. It was created...
Other Medicine News:Health News:Simpler Anemia Treatment May Help Kidney Patients 2Health News:Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 3Health News:Doctors Applaud SCHIP Veto: Bill Supports Special Interests, Not Kids; Almost Half of Funds Go to Doctors & Seniors 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 3
(Date:11/25/2009)...dsandJOHANNESBURG,November25/PRNewswire/--,iThemba...nouncedtoday,thattheyhavesignedacollaborativeagree... Pyxis,sworldclasscomputationalchemistryandleaddis...ivisiontoprovidemedicinaland,syntheticchemistrysup...lclientnetwork.iThembaPharmaceuticalsandPyxisDisco...
(Date:11/25/2009)....,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announce...ROTECT-1(theProspectiveRandomizedOralTherapyEvalua...-B)inpatientswithmoderate-to-severeCrohn,sdiseased...tolerabilityprofile.Thestudydemonstratedevidenceof...efinedasa70-pointdecreaseintheCrohn,sDiseaseActivi...
(Date:11/24/2009)...PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmantho...ent,wasactuallyfullyconsciousandawakeduringthattim...ynaVoxEyeMaxwasfeaturedinthesegmenttoillustratehow...lockcommunication. ,, WHEN:GoodMorningAmerica--...oxtech.com ,, WHO:RomHoubenswasanengineerin...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Emdeon Acquires eRx Network LLC 50665 1Emdeon Acquires eRx Network LLC 50665 2Emdeon Acquires eRx Network LLC 50665 3New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2
...cals, a division of Wyeth (NYSE: WYE ), announced...(FDA) has issued an approvable letter for,the firs... the treatment of,adult patients with community-ac..., the FDA requested that Wyeth provide,additional ...ACIL for the,treatment of patients with CAP with i...
...val Benefit in Complete and Partial Respo...HEIGHTS, N.J., May 29 Genta,Incorporated (OTC Bul...erm,followup from a Phase 3 trial of the Company,s...dium) Injection, in patients with chronic,lymphocy...data show that,patients who achieved either a comp...
Other Medicine Technology:Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4
O.R. Special Procedure Apron
Special Procedure Apron
Easy Wrap Apron
Disposable Monopolar NeedleElectrodes With Detachable Lead Wire
Medicine Products: